Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2016

Open Access 01-12-2016 | Review

Immunomodulation after ischemic stroke: potential mechanisms and implications for therapy

Authors: Cynthia Santos Samary, Paolo Pelosi, Pedro Leme Silva, Patricia Rieken Macedo Rocco

Published in: Critical Care | Issue 1/2016

Login to get access

Abstract

Brain injuries are often associated with intensive care admissions, and carry high morbidity and mortality rates. Ischemic stroke is one of the most frequent causes of injury to the central nervous system. It is now increasingly clear that human stroke causes multi-organ systemic disease. Brain inflammation may lead to opposing local and systemic effects. Suppression of systemic immunity by the nervous system could protect the brain from additional inflammatory damage; however, it may increase the susceptibility to infection. Pneumonia and urinary tract infection are the most common complications occurring in patients after stroke. The mechanisms involved in lung-brain interactions are still unknown, but some studies have suggested that inhibition of the cholinergic anti-inflammatory pathway and release of glucocorticoids, catecholamines, and damage-associated molecular patterns (DAMPs) are among the pathophysiological mechanisms involved in communication from the ischemic brain to the lungs after stroke. This review describes the modifications in local and systemic immunity that occur after stroke, outlines mechanisms of stroke-induced immunosuppression and their role in pneumonia, and highlights potential therapeutic targets to reduce post-stroke complications. Despite significant advances towards a better understanding of the pathophysiology of ischemic stroke-induced immunosuppression and stroke-associated pneumonia (SAP) in recent years, many unanswered questions remain. The true incidence and outcomes of SAP, especially in intensive care unit settings, have yet to be determined, as has the full extent of stroke-induced immunosuppression and its clinical implications.
Literature
1.
Seshadri S, Beiser A, Kelly-Hayes M, et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke. 2006;37(2):345–50.CrossRefPubMed
2.
Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6(2):182–7.CrossRefPubMed
3.
4.
Chamorro A, Urra X, Planas AM. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke. 2007;38(3):1097–103.CrossRefPubMed
5.
6.
Smith WS. Pathophysiology of focal cerebral ischemia: a therapeutic perspective. J Vasc Interv Radiol. 2004;15(1 Pt 2):S3–12.CrossRefPubMed
7.
Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol. 2014;115:157–88.CrossRefPubMed
8.
Simon RP, Swan JH, Griffiths T, et al. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 1984;226(4676):850–2.CrossRefPubMed
9.
Yilmaz G, Granger DN. Leukocyte recruitment and ischemic brain injury. Neuromol Med. 2010;12(2):193–204.CrossRef
10.
Renu A, Amaro S, Laredo C, et al. Relevance of blood-brain barrier disruption after endovascular treatment of ischemic stroke: dual-energy computed tomographic study. Stroke. 2015;46(3):673–9.CrossRefPubMed
11.
Gliem M, Mausberg AK, Lee JI, et al. Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann Neurol. 2012;71(6):743–52.CrossRefPubMed
12.
Clausen BH, Lambertsen KL, Babcock AA, et al. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation. 2008;5:46.CrossRefPubMedPubMedCentral
13.
Buck BH, Liebeskind DS, Saver JL, et al. Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke. 2008;39(2):355–60.CrossRefPubMed
14.
Harris AK, Ergul A, Kozak A, et al. Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke. BMC Neurosci. 2005;6:49.CrossRefPubMedPubMedCentral
15.
Cuartero MI, Ballesteros I, Moraga A, et al. N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARgamma agonist rosiglitazone. Stroke. 2013;44(12):3498–508.CrossRefPubMed
16.
17.
Kleinschnitz C, Kraft P, Dreykluft A, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood. 2013;121(4):679–91.CrossRefPubMedPubMedCentral
18.
Prass K, Meisel C, Hoflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;198(5):725–36.CrossRefPubMedPubMedCentral
19.
20.
21.
Meisel C, Schwab JM, Prass K, et al. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005;6(10):775–86.CrossRefPubMed
22.
Romer C, Engel O, Winek K, et al. Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke. J Neurosci. 2015;35(20):7777–94.CrossRefPubMed
23.
24.
Denes A, Ferenczi S, Kovacs KJ. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size. J Neuroinflammation. 2011;8:164.CrossRefPubMedPubMedCentral
25.
26.
Haeusler KG, Schmidt WU, Fohring F, et al. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis. 2008;25(1-2):50–8.CrossRefPubMed
27.
Ruhnau J, Schulze K, Gaida B, et al. Stroke alters respiratory burst in neutrophils and monocytes. Stroke. 2014;45(3):794–800.CrossRefPubMed
28.
Vogelgesang A, Grunwald U, Langner S, et al. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke. 2008;39(1):237–41.CrossRefPubMed
29.
Offner H, Subramanian S, Parker SM, et al. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol. 2006;176(11):6523–31.CrossRefPubMed
30.
Chamorro A, Horcajada JP, Obach V, et al. The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke. 2005;36(7):1495–500.CrossRefPubMed
31.
Offner H, Subramanian S, Parker SM, et al. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab. 2006;26(5):654–65.CrossRefPubMed
32.
Klehmet J, Harms H, Richter M, et al. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience. 2009;158(3):1184–93.CrossRefPubMed
33.
Chamorro A, Amaro S, Vargas M, et al. Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J Neurol Neurosurg Psychiatry. 2006;77(11):1279–81.CrossRefPubMedPubMedCentral
34.
Wong CH, Jenne CN, Lee WY, et al. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science. 2011;334(6052):101–5.CrossRefPubMed
35.
Urra X, Cervera A, Obach V, et al. Monocytes are major players in the prognosis and risk of infection after acute stroke. Stroke. 2009;40(4):1262–8.CrossRefPubMed
36.
Liesz A, Ruger H, Purrucker J, et al. Stress mediators and immune dysfunction in patients with acute cerebrovascular diseases. PloS One. 2013;8(9), e74839.CrossRefPubMedPubMedCentral
37.
Abraham E, Arcaroli J, Shenkar R. Activation of extracellular signal-regulated kinases, NF-kappa B, and cyclic adenosine 5'-monophosphate response element-binding protein in lung neutrophils occurs by differing mechanisms after hemorrhage or endotoxemia. J Immunol. 2001;166(1):522–30.CrossRefPubMed
38.
Yang M, Zhang H, Voyno-Yasenetskaya T, et al. Requirement of Gbetagamma and c-Src in D2 dopamine receptor-mediated nuclear factor-kappaB activation. Mol Pharmacol. 2003;64(2):447–55.CrossRefPubMed
39.
Bergquist J, Ohlsson B, Tarkowski A. Nuclear factor-kappa B is involved in the catecholaminergic suppression of immunocompetent cells. Ann NY Acad Sci. 2000;917:281–9.CrossRefPubMed
40.
Tung A, Herrera S, Fornal CA, et al. The effect of prolonged anesthesia with isoflurane, propofol, dexmedetomidine, or ketamine on neural cell proliferation in the adult rat. Anesth Analg. 2008;106(6):1772–7.CrossRefPubMed
41.
Haddad JJ, Saade NE, Safieh-Garabedian B. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J Neuroimmunol. 2002;133(1-2):1–19.CrossRefPubMed
42.
Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332(20):1351–62.CrossRefPubMed
43.
Emsley HC, Smith CJ, Gavin CM, et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol. 2003;139(1-2):93–101.CrossRefPubMed
44.
Marklund N, Peltonen M, Nilsson TK, et al. Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Int Med. 2004;256(1):15–21.CrossRef
45.
46.
47.
48.
Ottani A, Giuliani D, Mioni C, et al. Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke. J Cereb Blood Flow Metab. 2009;29(3):512–23.CrossRefPubMed
49.
Maouche K, Polette M, Jolly T, et al. {alpha}7 nicotinic acetylcholine receptor regulates airway epithelium differentiation by controlling basal cell proliferation. Am J Pathol. 2009;175(5):1868–82.CrossRefPubMedPubMedCentral
50.
dos Santos CC, Shan Y, Akram A, et al. Neuroimmune regulation of ventilator-induced lung injury. Am J Respir Crit Care Med. 2011;183(4):471–82.CrossRefPubMed
51.
Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Int Med. 2009;265(6):663–79.CrossRef
52.
Walter U, Knoblich R, Steinhagen V, et al. Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit. J Neurol. 2007;254(10):1323–9.CrossRefPubMed
53.
54.
Villarreal A, Aviles Reyes RX, Angelo MF, et al. S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-kappaB signaling. J Neurochem. 2011;117(2):321–32.CrossRefPubMed
55.
Johnston KC, Li JY, Lyden PD, et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke. 1998;29(2):447–53.CrossRefPubMed
56.
Teramoto S. Novel preventive and therapuetic strategy for post-stroke pneumonia. Expert Rev Neurother. 2009;9(8):1187–200.CrossRefPubMed
57.
Huang JY, Zhang DY, Yao Y, et al. Training in swallowing prevents aspiration pneumonia in stroke patients with dysphagia. J Int Med Res. 2006;34(3):303–6.CrossRefPubMed
58.
Arai T, Yoshimi N, Fujiwara H, et al. Serum substance P concentrations and silent aspiration in elderly patients with stroke. Neurology. 2003;61(11):1625–6.CrossRefPubMed
59.
Jia YX, Sekizawa K, Ohrui T, et al. Dopamine D1 receptor antagonist inhibits swallowing reflex in guinea pigs. Am J Physiol. 1998;274(1 Pt 2):R76–80.PubMed
60.
Harms H, Prass K, Meisel C, et al. Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PloS One. 2008;3(5), e2158.CrossRefPubMedPubMedCentral
61.
Millns B, Gosney M, Jack CI, et al. Acute stroke predisposes to oral gram-negative bacilli–a cause of aspiration pneumonia? Gerontology. 2003;49(3):173–6.CrossRefPubMed
62.
Yan L, Qing Y, Xingyi J, et al. Etiologic diagnosis and clinical treatment of multiple drug-resistant bacteria infection in elderly patients with stroke-associated pneumonia after neurosurgery. Cell Biochem Biophys. 2015;71(2):731–4.CrossRefPubMed
63.
Del Zoppo GJ, Saver JL, Jauch EC, et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40(8):2945–8.CrossRefPubMedPubMedCentral
64.
65.
Giraldi-Guimardes A, Rezende-Lima M, Bruno FP, et al. Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats. Brain Res. 2009;1266:108–20.CrossRefPubMed
66.
Chen L, Zhang G, Khan AA, et al. Clinical efficacy and meta-analysis of stem cell therapies for patients with brain ischemia. Stem Cells Int. 2016;2016:6129579.PubMedPubMedCentral
67.
Dziedzic T, Slowik A, Pera J, et al. Beta-blockers reduce the risk of early death in ischemic stroke. J Neurol Sci. 2007;252(1):53–6.CrossRefPubMed
68.
Maier IL, Karch A, Mikolajczyk R, et al. Effect of beta-blocker therapy on the risk of infections and death after acute stroke–a historical cohort study. PloS One. 2015;10(2), e0116836.CrossRefPubMedPubMedCentral
69.
Yan GM, Ni B, Weller M, et al. Depolarization or glutamate receptor activation blocks apoptotic cell death of cultured cerebellar granule neurons. Brain Res. 1994;656(1):43–51.CrossRefPubMed
70.
Diener HC, AlKhedr A, Busse O, et al. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study. J Neurol. 2002;249(5):561–8.CrossRefPubMed
Metadata
Title
Immunomodulation after ischemic stroke: potential mechanisms and implications for therapy
Authors
Cynthia Santos Samary
Paolo Pelosi
Pedro Leme Silva
Patricia Rieken Macedo Rocco
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2016
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-016-1573-1

Other articles of this Issue 1/2016

Critical Care 1/2016 Go to the issue

Research

The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients

Commentary

Muscle regeneration after sepsis

Research

Diagnosing sepsis is subjective and highly variable: a survey of intensivists using case vignettes

Research

Association between time of discharge from ICU and hospital mortality: a systematic review and meta-analysis

Research

Increasing survival after admission to UK critical care units following cardiopulmonary resuscitation

Commentary

Surrogate endpoints and competing risk of death in cardiac arrest research